Anadys Pharmaceuticals' P2P Acquisition

Anadys Pharmaceuticals raised a round of funding on October 17, 2011. Investors include Roche Holding.

Anadys Pharmaceuticals is a biopharmaceutical company committed to advancing patient care by discovering, developing and commercializing novel and powerful small molecule, anti-infective medicines. Th…

Articles about Anadys Pharmaceuticals' P2P Acquisition: